Highlights from 10th International Symposium on Targeted Alpha Therapy, TAT-10 - Results from #20

Viewing 21-31 of 31 articles

TAT-10: Session IV: Nanocarriers

TAT-10: Exploration of the Chemistry of Astatine; From Basic Research Towards Applied Questions

TAT-10: Progress in the [At211]-Astatination of Antibodies by Nuclephilic Approaches Using Aryliodonium Salts Precursors

TAT-10: Quality Assurance and Labeling Chemistry Qualification for cGMP Production of Astatine-211-labeled anti-CD45 Antibodies

TAT-10: Development of Effective Chelators for Th227 to be Used in Targeted Thorium Conjugates

TAT-10: Spectroscopic and Computational Studies of Actinium Coordination Chemistry

TAT-10: A Novel Micro-Actinium225-Bismuth212 Biomedical Generator System

TAT-10: US DOE Tri-Lab Research Effort to Provide Accelerator produced Ac225 for radiotherapy: 2017 Update

TAT-10: Production of a Thorium/Actinium Generator at the Canadian Nuclear Laboratories

TAT-10: Progress Toward an Alternate Method for Production of Ac-225

TAT-10: Radium 223 from Bench to Bedside, and Future Directions for Targeted Alpha Therapy

1
2